ArticleBMJ public health2026
Prevalence, awareness, treatment and control of diabetes in Guatemala: a nationally representative survey among reproductive-age women.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: There has been no nationally representative diabetes survey in Guatemala. The objectives of this study are (1) To provide national estimates for the prevalence of diabetes among women of reproductive age in Guatemala and (2) To assess indicators of diabetes care, including diagnosis, treatment and control in this setting. Methods: We analysed cross-sectional household survey data from the Epidemiological Health and Nutrition Surveillance System in Guatemala, collected between August 2018 and April 2019. The sample included non-pregnant women aged 15-49 with available HbA1c data. We estimated diabetes prevalence and the care cascade. Diabetes was defined as HbA1c ≥6.5% or use of glucose-lowering medication. Treatment was defined as use of medication or receiving dietary management. Control was defined as HbA1c <7%. Results: The sample consisted of 1504 women. The overall weighted prevalence of diabetes was 5.0% (95% CI 3.8% to 6.5%). Prevalence rose sharply with age, and women aged 40-49 years had a prevalence of 13.3% (95% CI 9.4% to 18.4%). Of all women with diabetes, 45.6% (95% CI 33.6% to 58.1%) had received a diagnosis, 33.6% (95% CI 25.8% to 49.0%) were treated, and 8.0% (95% CI 3.2% to 18.9%) were controlled. Conclusions: Diabetes among reproductive-age women in Guatemala poses a major public health challenge. There is a need for multisectoral efforts to strengthen the provision of diabetes prevention, diagnosis and treatment in Guatemala.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.